Stock Updates

How has Teva Pharmaceutical Industries Limited:(NYSE:TEVA) performed recently?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 47805.14. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 30.17, a forward P/E of 7.61 and EPS of 1.5. At a stock price of 45.19 (-0.15%) it has a dividend yield of 3.01%.

EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 12.92% and more long-term 5.36% after five years. EPS growth quarter over quarter is -67.40%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is 1.40%.

For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of -7.17%. For the last month performance for Teva Pharmaceutical Industries Limited is -11.96%. While the last quarter is -9.97% and half year, -18.96%. Finally for the year, performance is -20.08%.

The 52-week high for Teva Pharmaceutical Industries Limited, is at -30.79%, and for the 52-week low it comes to a value of 0.47%. The 20-day simple moving average is -12.39% and -17.03% for the 200-day simple moving average.

Volatility for the week is at 3.22%, and for the month it is 2.16%. Teva Pharmaceutical Industries Limited, has a target price of 68.36.

In terms of debt, long term debt/equity is 0.27, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.36. The gross margin is 57.70%, while operating margin is 17.70%, the profit margin is 6.90%. The current ratio is 1.3 and the quick ratio is 1.

Insider ownership is at 2.70%, with instituitional ownership at 59.30%. Teva Pharmaceutical Industries Limited has a payout ratio of 67.50%. With the total shares outstanding coming to 1057.87. The shares float is 1014.36, with the float short at 1.07%, with short ratio coming to 1.7.

In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 2.50%, with its returns on investment at 5.70%. Return on equity is 4.90%. So will the investors see the target price of 68.36, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment